MeSH term
Frequency | Condition_Probility | Humans | 14 | 0.0 |
Adult | 4 | 0.0 |
Cohort Studies | 2 | 0.0 |
Extracellular Matrix Proteins/*genetics | 6 | 7.0 |
Female | 5 | 0.0 |
*Genes, Dominant | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Male | 4 | 0.0 |
Middle Aged | 4 | 0.0 |
Pedigree | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 12 | 0.0 |
Comparative Study | 2 | 0.0 |
Macular Degeneration/*genetics | 3 | 6.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Aged | 3 | 0.0 |
Mutation | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 4 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Mice | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Pigment Epithelium of Eye/metabolism | 2 | 6.0 |
Precipitin Tests | 2 | 0.0 |
Transfection | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Extracellular Matrix Proteins/*genetics/*metabolism | 2 | 33.0 |
